S Virtanen, E Tala. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Administration, OralAdolescentAdultAlanine TransaminaseAspartate AminotransferasesCapsulesFemaleHumansMaleMiddle AgedRifampin/administration & dosageRifampin/bloodRifampin/pharmacologyRifampin/therapeutic useSarcina/drug effectsTabletsTime FactorsTuberculosis, Pulmonary/drug therapyTuberculosis, Pulmonary/metabolism
Substances: See more » CapsulesTabletsAspartate AminotransferasesAlanine TransaminaseRifampin
Year: 1974 PMID: 4426151 DOI: 10.1002/cpt1974165part1817
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN: 0009-9236 Impact factor: 6.875